C
Concurrence
Clinical AI agents for healthcare that extend care teams across patient intake, triage and 24/7 support
About Concurrence
Concurrence (formerly Amigo) is a clinical AI infrastructure company for healthcare, building and training AI agents that handle patient-facing clinical workflows — from intake and triage to 24/7 care navigation and post-visit support. Its proprietary “digital residency” model trains each agent across millions of simulated patient scenarios specific to a practice's population, reaching a 100% safety pass rate before real-patient interaction. The platform has logged over 3 million autonomous patient encounters with zero safety incidents and integrates natively with major EHR systems including Epic, Oracle Health and Athenahealth across more than 100 languages. Concurrence provides a shared healthcare data foundation (the “Health World Model”) with configured agent workflows, supervision and outcome evaluation, letting healthcare organizations extend their care teams without adding headcount. SOC 2 Type II, HIPAA, PIPEDA and PHIPA compliant. Backed by Madrona, Optum Ventures, General Catalyst and GSV Ventures, with $17M raised to date.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2026 | $11M | $44M | General Catalyst · Optum Ventures · GSV · Madrona Venture Group | ↗ |
| SEED✓Equity / VC | Sep 2025 | — | — | General Catalyst · GSV | ↗ |
Growth signals
Latest recorded traffic for Concurrence is 51K monthly website visits, up 96.2% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
General Catalyst
GSV
Series A2 investors entered at this stage
Madrona Venture Group
Optum Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Concurrence on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Concurrence’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







